Immunohistochemistry (IHC) of tissue microarray (TMA) samples showed that SCD expression in individual patients within a cancer type such as liver and colon cancer was variable, but this variability was much greater in GBM (Fig. 1, A to F). This evidence concerns the gene SCD and glioblastoma.